Referred to the House Committee on Energy and Commerce.
This resolution expresses the House of Representatives support for designating July 16, 2025, as "Glioblastoma Awareness Day" and lists nonbinding objectives such as encouraging public awareness, honoring patients and caregivers, and supporting research. It does not create new legal rights, appropriate funds, or change federal law—it is a formal statement by the House. The text highlights needs like molecular biomarker testing, continued investment in research including the Glioblastoma Therapeutics Network, and collaboration among government, private, and nonprofit groups.
This is a simple resolution acted on only in the House of Representatives; it must be adopted by a majority vote in the House, is not sent to the President, and does not have the force of law.
This non‑binding House resolution expresses support for designating July 16, 2025, as "Glioblastoma Awareness Day." It encourages public awareness, honors patients and caregivers, recognizes molecular biomarker testing, and urges collaborative research and continued investment, including mention of the Glioblastoma Therapeutics Network (GTN).
The resolution does not appropriate funds or create new statutory authorities.
This is a nonbinding House resolution designating an awareness day; it does not create law or require enactment.
Relative to its intended legislative type, this bill is a typical commemorative House resolution: it clearly defines the issue and purpose, designates a date, and issues expressions of support and encouragement without creating legal obligations or new authorities.
Liberal emphasizes pushing for concrete funding; conservatives stress avoiding new federal spending
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberal emphasizes pushing for concrete funding; conservatives stress avoiding new federal spending
Likely strongly supportive because the resolution highlights a deadly cancer, emphasizes research needs, and calls for continued investments.
It aligns with priorities for public health attention, patient support, and federal research infrastructure like the GTN.
Generally supportive because the resolution is nonbinding, honors patients, and promotes research collaboration.
Sees it as a modest, low‑cost step, while wanting clarity that it does not obligate new spending without appropriation.
Likely supportive of the awareness and honoring aspects but cautious about implications for federal spending or program expansion.
Views the resolution as acceptable if it remains symbolic and avoids unfunded mandates.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
This is a nonbinding House resolution designating an awareness day; it does not create law or require enactment.
The bill has not accumulated any surfaced votes yet.
Liberal emphasizes pushing for concrete funding; conservatives stress avoiding new federal spending
This is a nonbinding House resolution designating an awareness day; it does not create law or require enactment.
Relative to its intended legislative type, this bill is a typical commemorative House resolution: it clearly defines the issue and purpose, designates a date, and issues expressions of support and encouragement without…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.